[HTML][HTML] Gut microbiota and chemical-induced acute liver injury
T Chen, R Li, P Chen - Frontiers in physiology, 2021 - frontiersin.org
Background: Drug overdose or chemical exposures are the main causes of acute liver injury
(ALI). Severe liver injury can develop into liver failure that is an important cause of liver …
(ALI). Severe liver injury can develop into liver failure that is an important cause of liver …
[HTML][HTML] Hepatocellular carcinoma immunotherapy and the potential influence of gut microbiome
Disruptions in the human gut microbiome have been associated with a cycle of hepatocyte
injury and regeneration characteristic of chronic liver disease. Evidence suggests that the …
injury and regeneration characteristic of chronic liver disease. Evidence suggests that the …
[PDF][PDF] Single-cell RNA transcriptome landscape of hepatocytes and non-parenchymal cells in healthy and NAFLD mouse liver
Q Su, SY Kim, F Adewale, Y Zhou, C Aldler, M Ni… - Iscience, 2021 - cell.com
Nonalcoholic fatty liver disease (NAFLD) is a global health-care problem with limited
therapeutic options. To obtain a cellular resolution of pathogenesis, 82,168 single-cell …
therapeutic options. To obtain a cellular resolution of pathogenesis, 82,168 single-cell …
[HTML][HTML] The role of microbiota in primary sclerosing cholangitis and related biliary malignancies
B Özdirik, T Müller, A Wree, F Tacke… - International Journal of …, 2021 - mdpi.com
Primary sclerosing cholangitis (PSC) is an immune-related cholangiopathy characterized by
biliary inflammation, cholestasis, and multifocal bile duct strictures. It is associated with high …
biliary inflammation, cholestasis, and multifocal bile duct strictures. It is associated with high …
Ficus pandurata Hance Inhibits Ulcerative Colitis and Colitis‐Associated Secondary Liver Damage of Mice by Enhancing Antioxidation Activity
W Dai, X Zhan, W Peng, X Liu, W Peng… - … medicine and cellular …, 2021 - Wiley Online Library
Inflammatory bowel disease (IBD), a global disease threatening human health, is commonly
accompanied by secondary liver damage (SLD) mediated by the gut‐liver axis. Oxidative …
accompanied by secondary liver damage (SLD) mediated by the gut‐liver axis. Oxidative …
4-octyl itaconate supplementation relieves soybean diet-induced liver inflammation and glycolipid metabolic disorders by activating the nrf2-pparγ Pathway in juvenile …
L Fu, H Liu, W Cai, D Han, X Zhu… - Journal of Agricultural …, 2021 - ACS Publications
Itaconate is a promising new candidate for anti-inflammatory and metabolic reprogramming,
and 4-octyl itaconate (OI) is a cell-permeable itaconate derivative. To investigate the effect of …
and 4-octyl itaconate (OI) is a cell-permeable itaconate derivative. To investigate the effect of …
[HTML][HTML] The gut microbiota-derived immune response in chronic liver disease
In chronic liver disease, the causative factor is important; however, recently, the intestinal
microbiome has been associated with the progression of chronic liver disease and the …
microbiome has been associated with the progression of chronic liver disease and the …
Recurrent primary sclerosing cholangitis: current understanding, management, and future directions
Patients with primary sclerosing cholangitis (PSC) constitute 5 to 15% of patients listed for
liver transplantation worldwide. Although post-transplant outcomes are favorable, recurrent …
liver transplantation worldwide. Although post-transplant outcomes are favorable, recurrent …
" Gut-skin" axis: understanding psoriasis from the gut
Y Su, F Zhang, W Qin, L Wu, Q Wang… - Die Pharmazie-An …, 2021 - ingentaconnect.com
Background: The exact pathogenesis of psoriasis is complex, and scholars use the intestinal
mucosal immunity as an entry point to analyze the important role of the intestine in the …
mucosal immunity as an entry point to analyze the important role of the intestine in the …
活化自体淋巴细胞过继性免疫治疗在原发性肝细胞癌中的疗效观察.
杨岩丽, 廖丽, 张婧, 孙鹏, 张凤春… - Chinese Journal of …, 2021 - search.ebscohost.com
目的: 评价活化自体淋巴细胞过继性免疫治疗(adoptive immunotherapy, AIT)
是否有助于改善原发性肝细胞癌的临床疗效. 方法: 选取2016 年8 月至2018 年12 …
是否有助于改善原发性肝细胞癌的临床疗效. 方法: 选取2016 年8 月至2018 年12 …